EMAIL DIGESTS
Daily
Every morning
Weekly
Sunday recap
The new capital speeds the rollout of AI‑driven automation in clinical trials, which can shorten drug‑development timelines and lower operational costs, underscoring growing investor confidence in health‑tech solutions.
Want to join the conversation?
Loading comments...
Comments
Want to join the conversation?
Loading comments...